nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—CYP2C9—brain cancer	0.552	1	CbGaD
Pantoprazole—CYP1A2—Carmustine—brain cancer	0.0632	0.213	CbGbCtD
Pantoprazole—ABCG2—Carboplatin—brain cancer	0.0541	0.183	CbGbCtD
Pantoprazole—CYP3A4—Temozolomide—brain cancer	0.0477	0.161	CbGbCtD
Pantoprazole—ABCG2—Etoposide—brain cancer	0.0454	0.153	CbGbCtD
Pantoprazole—CYP3A4—Lomustine—brain cancer	0.0406	0.137	CbGbCtD
Pantoprazole—CYP1A2—Etoposide—brain cancer	0.0187	0.0633	CbGbCtD
Pantoprazole—ABCB1—Etoposide—brain cancer	0.0164	0.0553	CbGbCtD
Pantoprazole—CYP3A4—Etoposide—brain cancer	0.00981	0.0332	CbGbCtD
Pantoprazole—Rabeprazole—CYP2C9—brain cancer	0.00169	0.39	CrCbGaD
Pantoprazole—Omeprazole—CYP2C9—brain cancer	0.00137	0.318	CrCbGaD
Pantoprazole—Lansoprazole—CYP2C9—brain cancer	0.00126	0.291	CrCbGaD
Pantoprazole—Haemorrhage—Carmustine—brain cancer	0.000241	0.00167	CcSEcCtD
Pantoprazole—Ill-defined disorder—Hydroxyurea—brain cancer	0.000241	0.00167	CcSEcCtD
Pantoprazole—Anaemia—Hydroxyurea—brain cancer	0.00024	0.00167	CcSEcCtD
Pantoprazole—Hypoaesthesia—Carmustine—brain cancer	0.00024	0.00167	CcSEcCtD
Pantoprazole—Hallucination—Carmustine—brain cancer	0.00024	0.00167	CcSEcCtD
Pantoprazole—Decreased appetite—Procarbazine—brain cancer	0.000238	0.00165	CcSEcCtD
Pantoprazole—Alanine aminotransferase increased—Etoposide—brain cancer	0.000238	0.00165	CcSEcCtD
Pantoprazole—Oedema peripheral—Carmustine—brain cancer	0.000238	0.00165	CcSEcCtD
Pantoprazole—Connective tissue disorder—Carmustine—brain cancer	0.000237	0.00165	CcSEcCtD
Pantoprazole—Fatigue—Procarbazine—brain cancer	0.000236	0.00164	CcSEcCtD
Pantoprazole—Haemoglobin—Temozolomide—brain cancer	0.000234	0.00163	CcSEcCtD
Pantoprazole—Malaise—Hydroxyurea—brain cancer	0.000234	0.00163	CcSEcCtD
Pantoprazole—Constipation—Procarbazine—brain cancer	0.000234	0.00163	CcSEcCtD
Pantoprazole—Pain—Procarbazine—brain cancer	0.000234	0.00163	CcSEcCtD
Pantoprazole—Haemorrhage—Temozolomide—brain cancer	0.000233	0.00162	CcSEcCtD
Pantoprazole—Hepatitis—Temozolomide—brain cancer	0.000233	0.00162	CcSEcCtD
Pantoprazole—Dysphagia—Etoposide—brain cancer	0.000233	0.00162	CcSEcCtD
Pantoprazole—Leukopenia—Hydroxyurea—brain cancer	0.000232	0.00161	CcSEcCtD
Pantoprazole—Visual impairment—Carmustine—brain cancer	0.000232	0.00161	CcSEcCtD
Pantoprazole—Hallucination—Temozolomide—brain cancer	0.000232	0.00161	CcSEcCtD
Pantoprazole—Hypoaesthesia—Temozolomide—brain cancer	0.000232	0.00161	CcSEcCtD
Pantoprazole—Pharyngitis—Temozolomide—brain cancer	0.000231	0.00161	CcSEcCtD
Pantoprazole—Urinary tract disorder—Temozolomide—brain cancer	0.00023	0.0016	CcSEcCtD
Pantoprazole—Oedema peripheral—Temozolomide—brain cancer	0.00023	0.00159	CcSEcCtD
Pantoprazole—Connective tissue disorder—Temozolomide—brain cancer	0.000229	0.00159	CcSEcCtD
Pantoprazole—Urethral disorder—Temozolomide—brain cancer	0.000228	0.00159	CcSEcCtD
Pantoprazole—Sweating increased—Etoposide—brain cancer	0.000227	0.00158	CcSEcCtD
Pantoprazole—Feeling abnormal—Procarbazine—brain cancer	0.000226	0.00157	CcSEcCtD
Pantoprazole—Eye disorder—Carmustine—brain cancer	0.000225	0.00156	CcSEcCtD
Pantoprazole—Convulsion—Hydroxyurea—brain cancer	0.000225	0.00156	CcSEcCtD
Pantoprazole—Visual impairment—Temozolomide—brain cancer	0.000225	0.00156	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Procarbazine—brain cancer	0.000224	0.00155	CcSEcCtD
Pantoprazole—Flushing—Carmustine—brain cancer	0.000224	0.00155	CcSEcCtD
Pantoprazole—Pancytopenia—Etoposide—brain cancer	0.000221	0.00154	CcSEcCtD
Pantoprazole—Erythema multiforme—Temozolomide—brain cancer	0.00022	0.00153	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00022	0.00152	CcSEcCtD
Pantoprazole—Discomfort—Hydroxyurea—brain cancer	0.000218	0.00152	CcSEcCtD
Pantoprazole—Eye disorder—Temozolomide—brain cancer	0.000218	0.00151	CcSEcCtD
Pantoprazole—Urticaria—Procarbazine—brain cancer	0.000218	0.00151	CcSEcCtD
Pantoprazole—Tinnitus—Temozolomide—brain cancer	0.000217	0.00151	CcSEcCtD
Pantoprazole—Abdominal pain—Procarbazine—brain cancer	0.000216	0.0015	CcSEcCtD
Pantoprazole—Body temperature increased—Procarbazine—brain cancer	0.000216	0.0015	CcSEcCtD
Pantoprazole—Flushing—Temozolomide—brain cancer	0.000216	0.0015	CcSEcCtD
Pantoprazole—Arrhythmia—Carmustine—brain cancer	0.000215	0.0015	CcSEcCtD
Pantoprazole—Alopecia—Carmustine—brain cancer	0.000213	0.00148	CcSEcCtD
Pantoprazole—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000212	0.0628	CbGpPWpGaD
Pantoprazole—Oedema—Hydroxyurea—brain cancer	0.000212	0.00147	CcSEcCtD
Pantoprazole—Mental disorder—Carmustine—brain cancer	0.000211	0.00147	CcSEcCtD
Pantoprazole—Infection—Hydroxyurea—brain cancer	0.000211	0.00146	CcSEcCtD
Pantoprazole—Immune system disorder—Temozolomide—brain cancer	0.00021	0.00146	CcSEcCtD
Pantoprazole—Malnutrition—Carmustine—brain cancer	0.00021	0.00146	CcSEcCtD
Pantoprazole—Chills—Temozolomide—brain cancer	0.000209	0.00145	CcSEcCtD
Pantoprazole—Pneumonia—Etoposide—brain cancer	0.000209	0.00145	CcSEcCtD
Pantoprazole—Nervous system disorder—Hydroxyurea—brain cancer	0.000208	0.00144	CcSEcCtD
Pantoprazole—Infestation NOS—Etoposide—brain cancer	0.000208	0.00144	CcSEcCtD
Pantoprazole—Infestation—Etoposide—brain cancer	0.000208	0.00144	CcSEcCtD
Pantoprazole—Thrombocytopenia—Hydroxyurea—brain cancer	0.000207	0.00144	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000206	0.00143	CcSEcCtD
Pantoprazole—Alopecia—Temozolomide—brain cancer	0.000206	0.00143	CcSEcCtD
Pantoprazole—Skin disorder—Hydroxyurea—brain cancer	0.000206	0.00143	CcSEcCtD
Pantoprazole—Acute coronary syndrome—Etoposide—brain cancer	0.000205	0.00142	CcSEcCtD
Pantoprazole—Mental disorder—Temozolomide—brain cancer	0.000204	0.00142	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Etoposide—brain cancer	0.000204	0.00141	CcSEcCtD
Pantoprazole—Myocardial infarction—Etoposide—brain cancer	0.000204	0.00141	CcSEcCtD
Pantoprazole—Back pain—Carmustine—brain cancer	0.000203	0.00141	CcSEcCtD
Pantoprazole—Malnutrition—Temozolomide—brain cancer	0.000203	0.00141	CcSEcCtD
Pantoprazole—Jaundice—Etoposide—brain cancer	0.000202	0.00141	CcSEcCtD
Pantoprazole—Stomatitis—Etoposide—brain cancer	0.000202	0.00141	CcSEcCtD
Pantoprazole—Anorexia—Hydroxyurea—brain cancer	0.000202	0.0014	CcSEcCtD
Pantoprazole—Hypersensitivity—Procarbazine—brain cancer	0.000202	0.0014	CcSEcCtD
Pantoprazole—Dysgeusia—Temozolomide—brain cancer	0.000199	0.00138	CcSEcCtD
Pantoprazole—Vision blurred—Carmustine—brain cancer	0.000198	0.00137	CcSEcCtD
Pantoprazole—Tremor—Carmustine—brain cancer	0.000197	0.00137	CcSEcCtD
Pantoprazole—Asthenia—Procarbazine—brain cancer	0.000196	0.00136	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Etoposide—brain cancer	0.000196	0.00136	CcSEcCtD
Pantoprazole—Back pain—Temozolomide—brain cancer	0.000196	0.00136	CcSEcCtD
Pantoprazole—Anaemia—Carmustine—brain cancer	0.000194	0.00135	CcSEcCtD
Pantoprazole—Agranulocytosis—Etoposide—brain cancer	0.000194	0.00135	CcSEcCtD
Pantoprazole—Pruritus—Procarbazine—brain cancer	0.000194	0.00135	CcSEcCtD
Pantoprazole—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000193	0.0571	CbGpPWpGaD
Pantoprazole—Agitation—Carmustine—brain cancer	0.000193	0.00134	CcSEcCtD
Pantoprazole—Vision blurred—Temozolomide—brain cancer	0.000191	0.00133	CcSEcCtD
Pantoprazole—Tremor—Temozolomide—brain cancer	0.00019	0.00132	CcSEcCtD
Pantoprazole—Dyspnoea—Hydroxyurea—brain cancer	0.000189	0.00131	CcSEcCtD
Pantoprazole—Somnolence—Hydroxyurea—brain cancer	0.000188	0.00131	CcSEcCtD
Pantoprazole—Ill-defined disorder—Temozolomide—brain cancer	0.000188	0.00131	CcSEcCtD
Pantoprazole—Leukopenia—Carmustine—brain cancer	0.000188	0.0013	CcSEcCtD
Pantoprazole—Anaemia—Temozolomide—brain cancer	0.000187	0.0013	CcSEcCtD
Pantoprazole—Diarrhoea—Procarbazine—brain cancer	0.000187	0.0013	CcSEcCtD
Pantoprazole—Dyspepsia—Hydroxyurea—brain cancer	0.000187	0.0013	CcSEcCtD
Pantoprazole—Agitation—Temozolomide—brain cancer	0.000186	0.00129	CcSEcCtD
Pantoprazole—Hypoaesthesia—Etoposide—brain cancer	0.000186	0.00129	CcSEcCtD
Pantoprazole—Angioedema—Temozolomide—brain cancer	0.000185	0.00129	CcSEcCtD
Pantoprazole—Decreased appetite—Hydroxyurea—brain cancer	0.000184	0.00128	CcSEcCtD
Pantoprazole—Urinary tract disorder—Etoposide—brain cancer	0.000184	0.00128	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000183	0.00127	CcSEcCtD
Pantoprazole—Malaise—Temozolomide—brain cancer	0.000183	0.00127	CcSEcCtD
Pantoprazole—Urethral disorder—Etoposide—brain cancer	0.000183	0.00127	CcSEcCtD
Pantoprazole—Fatigue—Hydroxyurea—brain cancer	0.000183	0.00127	CcSEcCtD
Pantoprazole—Vertigo—Temozolomide—brain cancer	0.000182	0.00127	CcSEcCtD
Pantoprazole—Convulsion—Carmustine—brain cancer	0.000182	0.00126	CcSEcCtD
Pantoprazole—Leukopenia—Temozolomide—brain cancer	0.000182	0.00126	CcSEcCtD
Pantoprazole—Hypertension—Carmustine—brain cancer	0.000181	0.00126	CcSEcCtD
Pantoprazole—Pain—Hydroxyurea—brain cancer	0.000181	0.00126	CcSEcCtD
Pantoprazole—Constipation—Hydroxyurea—brain cancer	0.000181	0.00126	CcSEcCtD
Pantoprazole—Dizziness—Procarbazine—brain cancer	0.000181	0.00126	CcSEcCtD
Pantoprazole—Palpitations—Temozolomide—brain cancer	0.000179	0.00124	CcSEcCtD
Pantoprazole—Myalgia—Carmustine—brain cancer	0.000179	0.00124	CcSEcCtD
Pantoprazole—Chest pain—Carmustine—brain cancer	0.000179	0.00124	CcSEcCtD
Pantoprazole—Anxiety—Carmustine—brain cancer	0.000178	0.00124	CcSEcCtD
Pantoprazole—Cough—Temozolomide—brain cancer	0.000177	0.00123	CcSEcCtD
Pantoprazole—Erythema multiforme—Etoposide—brain cancer	0.000176	0.00122	CcSEcCtD
Pantoprazole—Convulsion—Temozolomide—brain cancer	0.000176	0.00122	CcSEcCtD
Pantoprazole—Hypertension—Temozolomide—brain cancer	0.000175	0.00122	CcSEcCtD
Pantoprazole—Feeling abnormal—Hydroxyurea—brain cancer	0.000175	0.00121	CcSEcCtD
Pantoprazole—Eye disorder—Etoposide—brain cancer	0.000174	0.00121	CcSEcCtD
Pantoprazole—Vomiting—Procarbazine—brain cancer	0.000174	0.00121	CcSEcCtD
Pantoprazole—Flushing—Etoposide—brain cancer	0.000173	0.0012	CcSEcCtD
Pantoprazole—Confusional state—Carmustine—brain cancer	0.000173	0.0012	CcSEcCtD
Pantoprazole—Arthralgia—Temozolomide—brain cancer	0.000173	0.0012	CcSEcCtD
Pantoprazole—Myalgia—Temozolomide—brain cancer	0.000173	0.0012	CcSEcCtD
Pantoprazole—Rash—Procarbazine—brain cancer	0.000173	0.0012	CcSEcCtD
Pantoprazole—Dermatitis—Procarbazine—brain cancer	0.000172	0.0012	CcSEcCtD
Pantoprazole—Anxiety—Temozolomide—brain cancer	0.000172	0.00119	CcSEcCtD
Pantoprazole—Headache—Procarbazine—brain cancer	0.000172	0.00119	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000172	0.00119	CcSEcCtD
Pantoprazole—Oedema—Carmustine—brain cancer	0.000171	0.00119	CcSEcCtD
Pantoprazole—Discomfort—Temozolomide—brain cancer	0.000171	0.00118	CcSEcCtD
Pantoprazole—Infection—Carmustine—brain cancer	0.00017	0.00118	CcSEcCtD
Pantoprazole—Dry mouth—Temozolomide—brain cancer	0.000169	0.00117	CcSEcCtD
Pantoprazole—Immune system disorder—Etoposide—brain cancer	0.000168	0.00117	CcSEcCtD
Pantoprazole—Thrombocytopenia—Carmustine—brain cancer	0.000168	0.00116	CcSEcCtD
Pantoprazole—Body temperature increased—Hydroxyurea—brain cancer	0.000168	0.00116	CcSEcCtD
Pantoprazole—Chills—Etoposide—brain cancer	0.000167	0.00116	CcSEcCtD
Pantoprazole—Tachycardia—Carmustine—brain cancer	0.000167	0.00116	CcSEcCtD
Pantoprazole—Confusional state—Temozolomide—brain cancer	0.000167	0.00116	CcSEcCtD
Pantoprazole—Anaphylactic shock—Temozolomide—brain cancer	0.000166	0.00115	CcSEcCtD
Pantoprazole—Oedema—Temozolomide—brain cancer	0.000166	0.00115	CcSEcCtD
Pantoprazole—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000165	0.0489	CbGpPWpGaD
Pantoprazole—Alopecia—Etoposide—brain cancer	0.000165	0.00114	CcSEcCtD
Pantoprazole—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000165	0.0487	CbGpPWpGaD
Pantoprazole—Infection—Temozolomide—brain cancer	0.000164	0.00114	CcSEcCtD
Pantoprazole—Anorexia—Carmustine—brain cancer	0.000163	0.00113	CcSEcCtD
Pantoprazole—Nausea—Procarbazine—brain cancer	0.000163	0.00113	CcSEcCtD
Pantoprazole—Nervous system disorder—Temozolomide—brain cancer	0.000162	0.00113	CcSEcCtD
Pantoprazole—Thrombocytopenia—Temozolomide—brain cancer	0.000162	0.00113	CcSEcCtD
Pantoprazole—Skin disorder—Temozolomide—brain cancer	0.000161	0.00112	CcSEcCtD
Pantoprazole—Hypotension—Carmustine—brain cancer	0.00016	0.00111	CcSEcCtD
Pantoprazole—Hyperhidrosis—Temozolomide—brain cancer	0.00016	0.00111	CcSEcCtD
Pantoprazole—Dysgeusia—Etoposide—brain cancer	0.000159	0.0011	CcSEcCtD
Pantoprazole—Anorexia—Temozolomide—brain cancer	0.000158	0.0011	CcSEcCtD
Pantoprazole—Back pain—Etoposide—brain cancer	0.000157	0.00109	CcSEcCtD
Pantoprazole—Hypersensitivity—Hydroxyurea—brain cancer	0.000156	0.00108	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Carmustine—brain cancer	0.000156	0.00108	CcSEcCtD
Pantoprazole—Muscle spasms—Etoposide—brain cancer	0.000156	0.00108	CcSEcCtD
Pantoprazole—Insomnia—Carmustine—brain cancer	0.000155	0.00108	CcSEcCtD
Pantoprazole—Paraesthesia—Carmustine—brain cancer	0.000154	0.00107	CcSEcCtD
Pantoprazole—Dyspnoea—Carmustine—brain cancer	0.000153	0.00106	CcSEcCtD
Pantoprazole—Somnolence—Carmustine—brain cancer	0.000152	0.00106	CcSEcCtD
Pantoprazole—Asthenia—Hydroxyurea—brain cancer	0.000152	0.00106	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000151	0.00105	CcSEcCtD
Pantoprazole—Ill-defined disorder—Etoposide—brain cancer	0.000151	0.00105	CcSEcCtD
Pantoprazole—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000151	0.0445	CbGpPWpGaD
Pantoprazole—Anaemia—Etoposide—brain cancer	0.00015	0.00104	CcSEcCtD
Pantoprazole—Insomnia—Temozolomide—brain cancer	0.00015	0.00104	CcSEcCtD
Pantoprazole—Decreased appetite—Carmustine—brain cancer	0.000149	0.00103	CcSEcCtD
Pantoprazole—Paraesthesia—Temozolomide—brain cancer	0.000149	0.00103	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Carmustine—brain cancer	0.000148	0.00103	CcSEcCtD
Pantoprazole—Dyspnoea—Temozolomide—brain cancer	0.000148	0.00102	CcSEcCtD
Pantoprazole—Somnolence—Temozolomide—brain cancer	0.000147	0.00102	CcSEcCtD
Pantoprazole—Pain—Carmustine—brain cancer	0.000146	0.00102	CcSEcCtD
Pantoprazole—Constipation—Carmustine—brain cancer	0.000146	0.00102	CcSEcCtD
Pantoprazole—Malaise—Etoposide—brain cancer	0.000146	0.00102	CcSEcCtD
Pantoprazole—Vertigo—Etoposide—brain cancer	0.000146	0.00101	CcSEcCtD
Pantoprazole—Dyspepsia—Temozolomide—brain cancer	0.000146	0.00101	CcSEcCtD
Pantoprazole—Leukopenia—Etoposide—brain cancer	0.000145	0.00101	CcSEcCtD
Pantoprazole—Diarrhoea—Hydroxyurea—brain cancer	0.000145	0.00101	CcSEcCtD
Pantoprazole—Decreased appetite—Temozolomide—brain cancer	0.000144	0.000999	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Temozolomide—brain cancer	0.000143	0.000992	CcSEcCtD
Pantoprazole—Fatigue—Temozolomide—brain cancer	0.000143	0.000991	CcSEcCtD
Pantoprazole—Loss of consciousness—Etoposide—brain cancer	0.000143	0.000991	CcSEcCtD
Pantoprazole—Cough—Etoposide—brain cancer	0.000142	0.000983	CcSEcCtD
Pantoprazole—Constipation—Temozolomide—brain cancer	0.000142	0.000983	CcSEcCtD
Pantoprazole—Pain—Temozolomide—brain cancer	0.000142	0.000983	CcSEcCtD
Pantoprazole—Feeling abnormal—Carmustine—brain cancer	0.000141	0.00098	CcSEcCtD
Pantoprazole—Convulsion—Etoposide—brain cancer	0.000141	0.000976	CcSEcCtD
Pantoprazole—Hypertension—Etoposide—brain cancer	0.00014	0.000973	CcSEcCtD
Pantoprazole—Dizziness—Hydroxyurea—brain cancer	0.00014	0.000973	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Carmustine—brain cancer	0.00014	0.000973	CcSEcCtD
Pantoprazole—Chest pain—Etoposide—brain cancer	0.000138	0.000959	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000137	0.000953	CcSEcCtD
Pantoprazole—Discomfort—Etoposide—brain cancer	0.000137	0.000948	CcSEcCtD
Pantoprazole—Feeling abnormal—Temozolomide—brain cancer	0.000136	0.000947	CcSEcCtD
Pantoprazole—Body temperature increased—Carmustine—brain cancer	0.000135	0.00094	CcSEcCtD
Pantoprazole—Abdominal pain—Carmustine—brain cancer	0.000135	0.00094	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Temozolomide—brain cancer	0.000135	0.00094	CcSEcCtD
Pantoprazole—Vomiting—Hydroxyurea—brain cancer	0.000135	0.000936	CcSEcCtD
Pantoprazole—Rash—Hydroxyurea—brain cancer	0.000134	0.000928	CcSEcCtD
Pantoprazole—Confusional state—Etoposide—brain cancer	0.000134	0.000927	CcSEcCtD
Pantoprazole—Dermatitis—Hydroxyurea—brain cancer	0.000133	0.000927	CcSEcCtD
Pantoprazole—Headache—Hydroxyurea—brain cancer	0.000133	0.000922	CcSEcCtD
Pantoprazole—Anaphylactic shock—Etoposide—brain cancer	0.000132	0.00092	CcSEcCtD
Pantoprazole—Infection—Etoposide—brain cancer	0.000132	0.000914	CcSEcCtD
Pantoprazole—Urticaria—Temozolomide—brain cancer	0.000132	0.000913	CcSEcCtD
Pantoprazole—Abdominal pain—Temozolomide—brain cancer	0.000131	0.000909	CcSEcCtD
Pantoprazole—Body temperature increased—Temozolomide—brain cancer	0.000131	0.000909	CcSEcCtD
Pantoprazole—Thrombocytopenia—Etoposide—brain cancer	0.00013	0.000901	CcSEcCtD
Pantoprazole—Tachycardia—Etoposide—brain cancer	0.000129	0.000898	CcSEcCtD
Pantoprazole—Skin disorder—Etoposide—brain cancer	0.000129	0.000893	CcSEcCtD
Pantoprazole—Hyperhidrosis—Etoposide—brain cancer	0.000128	0.000889	CcSEcCtD
Pantoprazole—Anorexia—Etoposide—brain cancer	0.000126	0.000877	CcSEcCtD
Pantoprazole—Hypersensitivity—Carmustine—brain cancer	0.000126	0.000876	CcSEcCtD
Pantoprazole—Nausea—Hydroxyurea—brain cancer	0.000126	0.000874	CcSEcCtD
Pantoprazole—Hypotension—Etoposide—brain cancer	0.000124	0.000859	CcSEcCtD
Pantoprazole—Asthenia—Carmustine—brain cancer	0.000123	0.000853	CcSEcCtD
Pantoprazole—Hypersensitivity—Temozolomide—brain cancer	0.000122	0.000847	CcSEcCtD
Pantoprazole—Paraesthesia—Etoposide—brain cancer	0.000119	0.000826	CcSEcCtD
Pantoprazole—Asthenia—Temozolomide—brain cancer	0.000119	0.000825	CcSEcCtD
Pantoprazole—Dyspnoea—Etoposide—brain cancer	0.000118	0.00082	CcSEcCtD
Pantoprazole—Somnolence—Etoposide—brain cancer	0.000118	0.000818	CcSEcCtD
Pantoprazole—Diarrhoea—Carmustine—brain cancer	0.000117	0.000814	CcSEcCtD
Pantoprazole—Pruritus—Temozolomide—brain cancer	0.000117	0.000813	CcSEcCtD
Pantoprazole—Decreased appetite—Etoposide—brain cancer	0.000115	0.0008	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Etoposide—brain cancer	0.000114	0.000794	CcSEcCtD
Pantoprazole—Fatigue—Etoposide—brain cancer	0.000114	0.000793	CcSEcCtD
Pantoprazole—Dizziness—Carmustine—brain cancer	0.000113	0.000787	CcSEcCtD
Pantoprazole—Pain—Etoposide—brain cancer	0.000113	0.000787	CcSEcCtD
Pantoprazole—Constipation—Etoposide—brain cancer	0.000113	0.000787	CcSEcCtD
Pantoprazole—Diarrhoea—Temozolomide—brain cancer	0.000113	0.000786	CcSEcCtD
Pantoprazole—Dizziness—Temozolomide—brain cancer	0.000109	0.00076	CcSEcCtD
Pantoprazole—Feeling abnormal—Etoposide—brain cancer	0.000109	0.000758	CcSEcCtD
Pantoprazole—Vomiting—Carmustine—brain cancer	0.000109	0.000756	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Etoposide—brain cancer	0.000108	0.000752	CcSEcCtD
Pantoprazole—Rash—Carmustine—brain cancer	0.000108	0.00075	CcSEcCtD
Pantoprazole—Dermatitis—Carmustine—brain cancer	0.000108	0.000749	CcSEcCtD
Pantoprazole—Headache—Carmustine—brain cancer	0.000107	0.000745	CcSEcCtD
Pantoprazole—Vomiting—Temozolomide—brain cancer	0.000105	0.000731	CcSEcCtD
Pantoprazole—Urticaria—Etoposide—brain cancer	0.000105	0.000731	CcSEcCtD
Pantoprazole—Abdominal pain—Etoposide—brain cancer	0.000105	0.000727	CcSEcCtD
Pantoprazole—Body temperature increased—Etoposide—brain cancer	0.000105	0.000727	CcSEcCtD
Pantoprazole—Rash—Temozolomide—brain cancer	0.000104	0.000725	CcSEcCtD
Pantoprazole—Dermatitis—Temozolomide—brain cancer	0.000104	0.000724	CcSEcCtD
Pantoprazole—Headache—Temozolomide—brain cancer	0.000104	0.00072	CcSEcCtD
Pantoprazole—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000102	0.0302	CbGpPWpGaD
Pantoprazole—Nausea—Carmustine—brain cancer	0.000102	0.000707	CcSEcCtD
Pantoprazole—Nausea—Temozolomide—brain cancer	9.83e-05	0.000683	CcSEcCtD
Pantoprazole—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	9.81e-05	0.029	CbGpPWpGaD
Pantoprazole—Hypersensitivity—Etoposide—brain cancer	9.76e-05	0.000678	CcSEcCtD
Pantoprazole—Asthenia—Etoposide—brain cancer	9.5e-05	0.00066	CcSEcCtD
Pantoprazole—Pruritus—Etoposide—brain cancer	9.37e-05	0.000651	CcSEcCtD
Pantoprazole—ATP4B—Ion channel transport—TRPC6—brain cancer	9.26e-05	0.0274	CbGpPWpGaD
Pantoprazole—Diarrhoea—Etoposide—brain cancer	9.06e-05	0.000629	CcSEcCtD
Pantoprazole—Dizziness—Etoposide—brain cancer	8.76e-05	0.000608	CcSEcCtD
Pantoprazole—Vomiting—Etoposide—brain cancer	8.42e-05	0.000585	CcSEcCtD
Pantoprazole—Rash—Etoposide—brain cancer	8.35e-05	0.00058	CcSEcCtD
Pantoprazole—Dermatitis—Etoposide—brain cancer	8.35e-05	0.000579	CcSEcCtD
Pantoprazole—Headache—Etoposide—brain cancer	8.3e-05	0.000576	CcSEcCtD
Pantoprazole—ATP4A—Ion channel transport—TRPC6—brain cancer	8.25e-05	0.0244	CbGpPWpGaD
Pantoprazole—CYP1A2—Xenobiotics—CYP2C9—brain cancer	7.95e-05	0.0235	CbGpPWpGaD
Pantoprazole—Nausea—Etoposide—brain cancer	7.87e-05	0.000546	CcSEcCtD
Pantoprazole—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	7.65e-05	0.0226	CbGpPWpGaD
Pantoprazole—SLCO1B1—Irinotecan Pathway—APC—brain cancer	7.02e-05	0.0207	CbGpPWpGaD
Pantoprazole—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	7.01e-05	0.0207	CbGpPWpGaD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—S100A10—brain cancer	6.98e-05	0.0206	CbGpPWpGaD
Pantoprazole—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	6.84e-05	0.0202	CbGpPWpGaD
Pantoprazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	6.51e-05	0.0193	CbGpPWpGaD
Pantoprazole—ABCG2—Irinotecan Pathway—APC—brain cancer	6.5e-05	0.0192	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—S100A10—brain cancer	6.22e-05	0.0184	CbGpPWpGaD
Pantoprazole—CYP3A4—Xenobiotics—CYP2C9—brain cancer	6.14e-05	0.0181	CbGpPWpGaD
Pantoprazole—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	5.9e-05	0.0174	CbGpPWpGaD
Pantoprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	5.2e-05	0.0154	CbGpPWpGaD
Pantoprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	4.93e-05	0.0146	CbGpPWpGaD
Pantoprazole—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	4.9e-05	0.0145	CbGpPWpGaD
Pantoprazole—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	4.49e-05	0.0133	CbGpPWpGaD
Pantoprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	4.39e-05	0.013	CbGpPWpGaD
Pantoprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	4.24e-05	0.0125	CbGpPWpGaD
Pantoprazole—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	4.21e-05	0.0125	CbGpPWpGaD
Pantoprazole—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	4.18e-05	0.0124	CbGpPWpGaD
Pantoprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	4.01e-05	0.0119	CbGpPWpGaD
Pantoprazole—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	3.82e-05	0.0113	CbGpPWpGaD
Pantoprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	3.43e-05	0.0102	CbGpPWpGaD
Pantoprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	3.3e-05	0.00976	CbGpPWpGaD
Pantoprazole—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	3.26e-05	0.00963	CbGpPWpGaD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—TRPC6—brain cancer	3.22e-05	0.00953	CbGpPWpGaD
Pantoprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	3.08e-05	0.00909	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—TRPC6—brain cancer	2.87e-05	0.00849	CbGpPWpGaD
Pantoprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	2.68e-05	0.00791	CbGpPWpGaD
Pantoprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	2.66e-05	0.00788	CbGpPWpGaD
Pantoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	2.55e-05	0.00753	CbGpPWpGaD
Pantoprazole—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	2.51e-05	0.00743	CbGpPWpGaD
Pantoprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	2.37e-05	0.00702	CbGpPWpGaD
Pantoprazole—CYP3A4—Irinotecan Pathway—APC—brain cancer	2.16e-05	0.0064	CbGpPWpGaD
Pantoprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	2.07e-05	0.00611	CbGpPWpGaD
Pantoprazole—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	1.92e-05	0.00567	CbGpPWpGaD
Pantoprazole—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	1.91e-05	0.00565	CbGpPWpGaD
Pantoprazole—CYP2C19—Biological oxidations—CYP2C9—brain cancer	1.82e-05	0.00539	CbGpPWpGaD
Pantoprazole—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	1.8e-05	0.00532	CbGpPWpGaD
Pantoprazole—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	1.76e-05	0.00521	CbGpPWpGaD
Pantoprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	1.66e-05	0.00492	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—S100A10—brain cancer	1.57e-05	0.00463	CbGpPWpGaD
Pantoprazole—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	1.48e-05	0.00437	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	1.47e-05	0.00434	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	1.45e-05	0.00429	CbGpPWpGaD
Pantoprazole—CYP1A2—Biological oxidations—CYP2C9—brain cancer	1.42e-05	0.0042	CbGpPWpGaD
Pantoprazole—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	1.4e-05	0.00414	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.37e-05	0.00404	CbGpPWpGaD
Pantoprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	1.31e-05	0.00388	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—PDGFRA—brain cancer	1.13e-05	0.00335	CbGpPWpGaD
Pantoprazole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	1.12e-05	0.00332	CbGpPWpGaD
Pantoprazole—CYP3A4—Biological oxidations—CYP2C9—brain cancer	1.1e-05	0.00324	CbGpPWpGaD
Pantoprazole—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	1.08e-05	0.0032	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	9.99e-06	0.00295	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	9.46e-06	0.0028	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	8.97e-06	0.00265	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	8.46e-06	0.0025	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	7.85e-06	0.00232	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	7.62e-06	0.00225	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	7.57e-06	0.00224	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	7.24e-06	0.00214	CbGpPWpGaD
Pantoprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	7.09e-06	0.0021	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.01e-06	0.00207	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	6.7e-06	0.00198	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	6.47e-06	0.00191	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	6.22e-06	0.00184	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—IL2—brain cancer	6.19e-06	0.00183	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	6.1e-06	0.0018	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYP2C9—brain cancer	6.08e-06	0.0018	CbGpPWpGaD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	6.08e-06	0.0018	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	6.02e-06	0.00178	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	5.96e-06	0.00176	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	5.83e-06	0.00172	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	5.83e-06	0.00172	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYP2C9—brain cancer	5.63e-06	0.00167	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	5.6e-06	0.00166	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.46e-06	0.00161	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	5.34e-06	0.00158	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—VEGFA—brain cancer	5.26e-06	0.00156	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—BSG—brain cancer	5.17e-06	0.00153	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.12e-06	0.00151	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—BSG—brain cancer	4.79e-06	0.00142	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.67e-06	0.00138	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	4.61e-06	0.00136	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—IDH1—brain cancer	4.45e-06	0.00131	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	4.34e-06	0.00128	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—IDH1—brain cancer	4.12e-06	0.00122	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.99e-06	0.00118	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.62e-06	0.00107	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.62e-06	0.00107	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ENO2—brain cancer	3.52e-06	0.00104	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.37e-06	0.000997	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ENO2—brain cancer	3.26e-06	0.000962	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP2C9—brain cancer	3.12e-06	0.000922	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP2C9—brain cancer	3.05e-06	0.0009	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.98e-06	0.000881	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.95e-06	0.000872	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—BSG—brain cancer	2.65e-06	0.000784	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.6e-06	0.000768	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—BSG—brain cancer	2.59e-06	0.000766	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP2C9—brain cancer	2.43e-06	0.000719	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—BSG—brain cancer	2.42e-06	0.000715	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.39e-06	0.000706	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.34e-06	0.000691	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—IDH1—brain cancer	2.28e-06	0.000674	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—IDH1—brain cancer	2.23e-06	0.000658	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—IDH1—brain cancer	2.08e-06	0.000615	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—BSG—brain cancer	2.07e-06	0.000611	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.96e-06	0.00058	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP2C9—brain cancer	1.88e-06	0.000555	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.86e-06	0.000549	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ENO2—brain cancer	1.8e-06	0.000533	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—IDH1—brain cancer	1.78e-06	0.000526	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ENO2—brain cancer	1.76e-06	0.00052	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.69e-06	0.000501	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ENO2—brain cancer	1.64e-06	0.000486	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CG—brain cancer	1.61e-06	0.000477	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—BSG—brain cancer	1.6e-06	0.000472	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CG—brain cancer	1.49e-06	0.000442	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.45e-06	0.000428	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ENO2—brain cancer	1.41e-06	0.000415	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—IDH1—brain cancer	1.37e-06	0.000406	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ENO2—brain cancer	1.08e-06	0.000321	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CG—brain cancer	8.27e-07	0.000245	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CG—brain cancer	8.07e-07	0.000239	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CG—brain cancer	7.54e-07	0.000223	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CG—brain cancer	6.45e-07	0.000191	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CG—brain cancer	4.97e-07	0.000147	CbGpPWpGaD
